C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CAN Equity

Cann Group

ASX · CAN

$0.00
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Underweight Conviction 1/5
30/100 composite
Fundamentals23
Regulatory56
Market15
Editorial30
Composite · trailing 12 months

Cann Group earns an Underweight rating, with a composite score near 30 and conviction at one out of five. The regulatory pillar leads at 56, supported by Australia’s jurisdiction posture score of 72 and an enforcement subscore of 80. That relative strength fails to offset a fundamentals pillar of 23, where operating profitability, market-cap tier, and cash runway score poorly. The market pillar contributes only 15 because recorded trading volume is nil, while the editorial pillar reaches 30 despite no newsroom or brief activity. The resulting profile combines limited market validation, weak operating economics, and stretched financial condition.

Licensed fundamentals data show year-over-year revenue contraction of roughly 30%, sharply reducing the basis for operating leverage. Gross margin remains comparatively constructive at approximately 46%, reflected in a gross-margin subscore of 76, but the operating margin stands near negative 133% and EBITDA is negative by about $7.2 million. Reported net income of roughly $14.7 million does not alter the stretched assessment given the EBITDA loss, a cash-burn ratio above one, and a cash-runway subscore of 15. Market capitalization is approximately $6.6 million, consistent with a zero market-cap-tier subscore. Primary regulatory filings show no recorded events across either the 90-day or 180-day windows, no enforcement hits, and no available latest-filing date; accordingly, filing cadence scores only 25. Institutional pricing feeds and CIN newsroom coverage add no stronger offset, with zero volume and no coverage hits.

The clearest rerating catalyst sits within the regulatory pillar, already the strongest component of the scorecard. Australia’s favorable jurisdiction posture and the absence of enforcement hits provide a platform for improvement, but the low cadence score prevents that platform from carrying greater weight. More regular primary regulatory filings could raise transparency, document operational progress, and strengthen confidence in reported financial trends without relying on thin trading activity or sparse editorial attention. Such progress would also create a firmer bridge between the 46% gross margin and any eventual narrowing of the deeply negative operating margin. The single most important signal to watch is the appearance of a current primary regulatory filing that establishes a consistent reporting cadence.

Scored: 2026-09-22Valid through: 2026-11-06Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
28 AYER RAJAH CRESCENT, #06-08, SINGAPORE, U0, 139959
Phone
65 6305 6618
CEO
Mike Ryan (Interim Executive Chairman)
CFO
David Hine
Auditor
KPMG Huazhen LLP
SEC CIK
1780652
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$6.6M
Enterprise value
$20.6M
P/E ratio
0.4
Price to book
0.22
Price to sales
0.66
EV / EBITDA
0.73
Revenue (TTM)
$11.3M
Gross profit (TTM)
$5.2M
EBITDA
$-7.2M
Operating margin
-132.8%
Profit margin
130.3%
Rev growth YoY
-30.1%
Return on equity
72.6%
Return on assets
-13.0%
EPS (TTM)
$0.01
Wall St. target price
$5.00
Shares outstanding
1,660.6M
Insider ownership
22.0%
Institutional ownership
3.6%
Beta
0.11
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Filing portal
ASX Announcements
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Cann Group (CAN)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Cann Group (CAN), a cannabis-sector equity listed on ASX. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

Analyst average price target $1.57.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, micro-cap. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CAN are maintained by Cannabis Investor News and refreshed throughout the trading day.